Clinical, histological, and genetic characterization of PYROXD1-related myopathy.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
27 08 2019
Historique:
received: 20 06 2019
accepted: 25 07 2019
entrez: 29 8 2019
pubmed: 29 8 2019
medline: 31 7 2020
Statut: epublish

Résumé

Recessive mutations in PYROXD1, encoding an oxidoreductase, were recently reported in families with congenital myopathy or limb-girdle muscular dystrophy. Here we describe three novel PYROXD1 families at the clinical, histological, and genetic level. Histological analyses on muscle biopsies from all families revealed fiber size variability, endomysial fibrosis, and muscle fibers with multiple internal nuclei and cores. Further characterization of the structural muscle defects uncovered aggregations of myofibrillar proteins, and provided evidence for enhanced oxidative stress. Sequencing identified homozygous or compound heterozygous PYROXD1 mutations including the first deep intronic mutation reinforcing a cryptic donor splice site and resulting in mRNA instability through exonisation of an intronic segment. Overall, this work expands the PYROXD1 mutation spectrum, defines and specifies the histopathological hallmarks of the disorder, and indicates that oxidative stress contributes to the pathomechanism. Comparison of all new and published cases uncovered a genotype/phenotype correlation with a more severe and early-onset phenotypic presentation of patients harboring splice mutations resulting in reduced PYROXD1 protein levels compared with patients carrying missense mutations.

Identifiants

pubmed: 31455395
doi: 10.1186/s40478-019-0781-8
pii: 10.1186/s40478-019-0781-8
pmc: PMC6710884
doi:

Substances chimiques

Oxidoreductases Acting on Sulfur Group Donors EC 1.8.-
PYROXD1 protein, human EC 1.8.1.-

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

138

Subventions

Organisme : Université de Strasbourg
ID : ANR-10-LABX-0030
Pays : International
Organisme : France Génomique
ID : ANR-10-INBS-09
Pays : International
Organisme : Association Française contre les Myopathies
ID : AFM-16992, AFM-17088, AFM-21267
Pays : International

Références

Curr Neurol Neurosci Rep. 2012 Apr;12(2):165-74
pubmed: 22392505
Free Radic Biol Med. 1991;11(3):239-46
pubmed: 1937141
Physiol Genomics. 2018 Nov 1;50(11):929-939
pubmed: 30345904
Neurology. 2014 May 20;82(20):1822-30
pubmed: 24759841
Handb Clin Neurol. 2013;113:1321-36
pubmed: 23622357
J Neurol. 2019 Feb;266(2):353-360
pubmed: 30515627
J Appl Physiol (1985). 1992 Feb;72(2):549-54
pubmed: 1559931
Nat Rev Mol Cell Biol. 2004 Feb;5(2):89-99
pubmed: 15040442
Handb Clin Neurol. 2018;148:549-564
pubmed: 29478600
Am J Hum Genet. 2016 Nov 3;99(5):1086-1105
pubmed: 27745833
Skelet Muscle. 2015 Apr 18;5:10
pubmed: 26075051

Auteurs

Xavière Lornage (X)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France.
Inserm U1258, Illkirch, France.
CNRS UMR7104, Illkirch, France.
Strasbourg University, Illkirch, France.

Vanessa Schartner (V)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France.
Inserm U1258, Illkirch, France.
CNRS UMR7104, Illkirch, France.
Strasbourg University, Illkirch, France.

Inès Balbueno (I)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France.
Inserm U1258, Illkirch, France.
CNRS UMR7104, Illkirch, France.
Strasbourg University, Illkirch, France.

Valérie Biancalana (V)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France.
Inserm U1258, Illkirch, France.
CNRS UMR7104, Illkirch, France.
Strasbourg University, Illkirch, France.
Laboratoire de Diagnostic Génétique, Faculté de Médecine, CHRU, Strasbourg, France.

Tracey Willis (T)

Wolfson Centre of Inherited Neuromuscular Disorders, RJAH Orthopaedic Hospital, Oswestry, UK.

Andoni Echaniz-Laguna (A)

Department of Neurology, APHP, CHU de Bicêtre, Le Kremlin Bicêtre, France.
French National Reference Center for Rare Neuropathies (NNERF), Le Kremlin Bicêtre, France.
Inserm U1195 & Paris-Sud University, Le Kremlin Bicêtre, France.

Sophie Scheidecker (S)

Laboratoire de Génétique Médicale, Strasbourg University, Strasbourg, France.

Ros Quinlivan (R)

MRC Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, UK.

Michel Fardeau (M)

Université Sorbonne, UPMC Paris 06 University, Inserm UMRS974, CNRS FRE3617, Center for Research in Myology, GH Pitié-Salpêtrière, Paris, France.
Centre de Référence de Pathologie Neuromusculaire Paris-Est, Institut de Myologie, GHU Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Neuromuscular Morphology Unit, Myology Institute, GHU Pitié-Salpêtrière, Paris, France.

Edoardo Malfatti (E)

Service Neurologie Médicale, Centre de Référence Maladies Neuromusculaire Paris-Nord, CHU Raymond-Poincaré, Garches, U1179 UVSQ-INSERM Handicap Neuromusculaire: Physiologie, Biothérapie et Pharmacologie appliquées, UFR des sciences de la santé Simone Veil, Université Versailles-Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.

Béatrice Lannes (B)

Department of Pathology, Strasbourg University Hospital, Strasbourg, France.

Caroline Sewry (C)

Wolfson Centre of Inherited Neuromuscular Disorders, RJAH Orthopaedic Hospital, Oswestry, UK.
Dubowitz Neuromuscular Centre, UCL Institute for Child Health and Great Ormond Street Hospital, London, UK.

Norma B Romero (NB)

Université Sorbonne, UPMC Paris 06 University, Inserm UMRS974, CNRS FRE3617, Center for Research in Myology, GH Pitié-Salpêtrière, Paris, France.
Centre de Référence de Pathologie Neuromusculaire Paris-Est, Institut de Myologie, GHU Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Neuromuscular Morphology Unit, Myology Institute, GHU Pitié-Salpêtrière, Paris, France.

Jocelyn Laporte (J)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France. jocelyn@igbmc.fr.
Inserm U1258, Illkirch, France. jocelyn@igbmc.fr.
CNRS UMR7104, Illkirch, France. jocelyn@igbmc.fr.
Strasbourg University, Illkirch, France. jocelyn@igbmc.fr.

Johann Böhm (J)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1 rue Laurent Fries, 67404, Illkirch, France. johann@igbmc.fr.
Inserm U1258, Illkirch, France. johann@igbmc.fr.
CNRS UMR7104, Illkirch, France. johann@igbmc.fr.
Strasbourg University, Illkirch, France. johann@igbmc.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH